bioRxiv Science⌕ Search

Biology subjects

Pernet, E.

Publications and source records attributed to Pernet, E..

4 recordsLinked to original sources

cGAS integrates Toll-like receptor signaling in platelets to promote thromboinflammation

Thromboinflammation is driven by innate immune signaling and promotes tissue injury during sepsis. Activation of platelets by bacterial products and alarmins amplifies inflammation, coagulation, and thrombotic dysfunction. However, the mechanisms by which these diverse inflammatory signals converge to elicit common platelet responses remain largely undefined. Mitochondria are key integrators of cellular stress responses and can activate innate immune pathways through the release of mitochondrial DNA and engagement of the DNA sensor cGAS. We therefore hypothesized that stimulation of innate immune receptors generates endogenous cGAS ligands within platelets, providing a unifying mechanism by which distinct inflammatory cues converge on cGAS-STING signaling. Here, we demonstrate that activation of TLR4, TLR1/2, and TLR5 engages a platelet-intrinsic mtDNA-cGAS-STING axis that promotes platelet activation. In a model of endotoxemia, genetic deletion of cGAS reduced platelet activation, thrombocytopenia, pyroptosis and the early systemic inflammatory response. Platelet transfer experiments further established that platelet-intrinsic cGAS is sufficient to amplify inflammatory responses in vivo. Mechanistically, we demonstrated that cytosolic accumulation of mtDNA and activation of cGAS-STING signaling pathway in platelets are dependent on mitochondrial calcium uniporter (MCU) and correlated with the loss of mitochondrial membrane potential and the production of mitochondrial reactive oxygen species. In contrast, canonical platelet agonists activated platelets independently of cGAS and failed to induce substantial cytosolic mtDNA accumulation. Importantly, this signaling architecture was conserved in human platelets, where TLR1/2-mediated activation required MCU- and STING-dependent signaling, whereas responses to thrombin receptor-activating peptide and collagen-related peptide remained largely unaffected. Together, these findings identify cGAS as an intracellular signal integration node that allows diverse innate immune receptors to converge on a common platelet activation pathway through sensing of mitochondria-derived DNA, allowing a rapid platelet response to microbial products.

cell biology↗

β-Glucan Reprograms Neutrophils to Induce Disease Tolerance Against Influenza A Virus

ABSTRACTDisease tolerance is an evolutionarily conserved host defence strategy that preserves tissue integrity and physiology without affecting pathogen load. Unlike host resistance, the mechanisms underlying disease tolerance remain poorly understood. In the present study, we investigated whether an adjuvant ({beta}-glucan) can reprogram innate immunity to provide protection against Influenza A virus (IAV) infection. Here we observe that {beta}-glucan treatment reduced the morbidity and mortality against IAV infection, independent of host resistance (viral load). Increased survival of {beta}-glucan treated mice against IAV is associated with the accumulation of neutrophils via RoR{gamma}t+ T cells in the lung tissue. Using gain-and-loss-of-function approaches, we demonstrate that {beta}- glucan reprogrammed neutrophils are essential for promoting disease tolerance, limiting pulmonary tissue damage, and enhancing survival against IAV infection. {beta}-glucan treatment promotes granulopoiesis in a type 1 interferon-dependent manner that leads to the generation of a unique subset of neutrophils, which are less mature with higher mitochondrial mass utilizing mitochondrial oxidative (OXPHOS) metabolism. Collectively, our data indicate that {beta}-glucan reprograms hematopoietic stem cells (HSCs) to generate neutrophils with a novel "regulatory" function, which is required for promoting disease tolerance and maintaining lung tissue integrity against viral infection.

immunology↗

β-glucan reprograms alveolar macrophages via neutrophil/IFNγ axis to promote lung injury

Alveolar macrophages (AMs) reside in the lower airways and play a crucial role in lung health and response to sterile inflammation and infections. AMs possess remarkable adaptability to different environmental challenges that can persist through their memory capacity (trained immunity). {beta}-glucan has been characterized as a potent inducer of central trained immunity by reprogramming hematopoietic stem cells (HSCs) in the bone marrow. In the present study, we show that systemic administration of {beta}-glucan induces peripheral trained immunity by reprogramming alveolar macrophages (AMs) in the lungs, in a Dectin1-independent manner. We furthermore demonstrate that AM reprogramming at both the transcriptional and metabolic levels exacerbate lung injury following bacterial (LPS) or viral (polyI:C) challenges via a neutrophil/IFN-{gamma} dependent manner. These findings identify an additional facet of {beta}-glucan in trained immunity involving AM reprogramming and shed light on the potential detrimental effects of trained immunity.

immunology↗

Mitochondrial cyclophilin D promotes disease tolerance by licensing NK cell development and IL-22 production against influenza virus

Immunity to infectious disease involves a combination of host resistance, which eliminates the pathogen, and disease tolerance, which limits tissue damage. While the severity of most pulmonary viral infections, including influenza A virus (IAV), is linked to excessive inflammation, our mechanistic understanding of this observation remains largely unknown. Here we show that mitochondrial cyclophilin D (CypD) protects against IAV infection via disease tolerance. Mice deficient in CypD (CypD-/- mice) are significantly more susceptible to IAV infection despite comparable antiviral immunity. Instead, this susceptibility resulted from damage to the lung epithelial barrier caused by a significant reduction of IL-22 production by conventional NK cells in IAV-infected CypD-/- mice. Transcriptomic and functional data revealed that the compromised IL-22 production by NK cells resulted from dysregulated lymphopoiesis, stemming from increased cell death in NK cell progenitors, as well as the generation of immature NK cells that exhibited altered mitochondrial metabolism. Importantly, following IAV infection, administration of recombinant IL-22 abrogated pulmonary damage and enhanced survival of CypD-/- mice. Collectively, these results demonstrate a key role for CypD in NK cell-mediated disease tolerance.

immunology↗